Gaxos.ai Inc. Common Stock
GXAIGaxos.ai Inc. (GXAI) is a technology company specializing in artificial intelligence solutions. It focuses on developing innovative AI-driven platforms and tools aimed at enhancing efficiency and decision-making across various industries. The company's offerings typically include machine learning algorithms, automation systems, and data analytics services to help businesses optimize operations and gain competitive advantages.
Company News
Gaxos.ai (NASDAQ: GXAI) acquired a 19.99% stake in America First Defense (AFD), a U.S.-based defense technology company developing counter-drone systems and biomimetic soft robotics platforms. The strategic investment expands Gaxos beyond AI content tools into defense technology, targeting demand from government and security agencies. The move fo...
Gaxos.ai Inc. announced the closing of a $5 million registered direct offering, issuing 1,449,277 shares of common stock at $3.45 per share. The company also issued warrants to purchase up to 1,449,277 shares at $3.32 per share. The proceeds will be used for working capital and general corporate purposes.
Gaxos.ai Inc. (GXAI) announced the exercise of existing warrants and the issuance of new warrants, raising approximately $3.24 million. The company plans to use the proceeds for working capital and general corporate purposes.
Gaxos.AI has partnered with Meshy to integrate the latter's 3D generative AI features into Gaxos' product for game developers and publishers, allowing them to create detailed and immersive 3D models more easily.
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.
